InterMune is a values-driven organization that works to embody integrity, passion, accountability, creativity and teamwork in bringing new treatments and hope to patients and families around the world. Our focus is research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), a progressive, irreversible, unpredictable and ultimately fatal lung disease. Pirfenidone, the only medicine approved for IPF, is marketed by InterMune in the EU and Canada as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States.
Company Details
- Employees
- 83
- Founded
- -
- Phone
- (415) 466-2200
- ir****@****une.com
- Industry
- Biotechnology
- Website
- intermune.com
Intermune Questions
Intermune's helpline number is (415) 466-2200
Intermune's website is intermune.com
Intermune's LinkedIn profile is https://www.linkedin.com/company/intermune
Intermune has
83 employees.
View email and phone details for 83
employees at Intermune.
Intermune's industry is
Biotechnology
Intermune's top competitors are
Actelion (Now Janssen Pulmonary Hypertension),
Adamas Pharmaceuticals, Inc.,
Novartis,
Ultragenyx,
Amgen,
Celgene,
Ipsen,
Sarepta Therapeutics,
Biomarin Pharmaceutical Inc.,
Sanofi.
Intermune's support email address is ir@intermune.com
Intermune's categories are Biotechnology
Intermune's founding year is 1998
